INBX vs GILD: Which Stock is Better?
Side-by-side comparison of Inhibrx Biosciences Inc and Gilead Sciences Inc in 2026
INBX
Inhibrx Biosciences Inc
$88.23
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | INBX | GILD | Winner |
|---|---|---|---|
| Market Cap | $1.29B | $170.84B | GILD |
| P/E Ratio | N/A | 20.27 | GILD |
| EPS (TTM) | $N/A | $6.79 | GILD |
| Revenue Growth | -1.0% | 0.0% | GILD |
| Gross Margin | -8594.5% | 78.8% | GILD |
Analyze INBX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INBX or GILD a better investment?
Comparing INBX and GILD: Inhibrx Biosciences Inc has a market cap of $1.29B while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INBX and GILD?
INBX (Inhibrx Biosciences Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INBX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INBX or GILD?
GILD has higher revenue growth at 0.0% vs -1.0% for INBX.
Which company is more profitable: INBX or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -8594.5% for INBX.
Which is the larger company: INBX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $1.29B for INBX.
Should I buy INBX or GILD in 2026?
Both INBX and GILD have investment merit. INBX trades at $88.23 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INBX and GILD stock?
Key differences: Market Cap ($1.29B vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (-8594.5% vs 78.8%).